Chemotherapy of brain tumors: physiological and pharmacokinetic considerations.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 3513317)

Published in Semin Oncol on March 01, 1986

Authors

R G Blasberg, D R Groothuis

Articles by these authors

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab (1983) 9.59

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab (1985) 5.99

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab (1993) 2.28

Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res (1996) 2.22

Imaging the expression of transfected genes in vivo. Cancer Res (1995) 2.05

Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab (1983) 1.80

Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther (1975) 1.63

The human thalamocortical sensory path in the internal capsule: evidence from a small capsular hemorrhage causing a pure sensory stroke. Ann Neurol (1977) 1.51

Specificity of cerebral amino acid transport: a kinetic analysis. Prog Brain Res (1968) 1.38

Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc Res (1999) 1.38

Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1999) 1.26

Midazolam changes cerebral blood flow in discrete brain regions: an H2(15)O positron emission tomography study. Anesthesiology (1997) 1.25

A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia (1999) 1.25

Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol (1982) 1.24

Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res (1999) 1.24

Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther (2002) 1.16

Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Cancer Res (1998) 1.12

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res (2001) 1.12

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. J Neurooncol (1994) 1.09

Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J Neurosurg (1996) 1.06

An evaluation of errors in the determination of blood flow by the indicator fractionation and tissue equilibration (Kety) methods. J Cereb Blood Flow Metab (1984) 1.05

Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery. Cancer (1983) 1.04

Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts. Cancer Res (1988) 1.04

Quantitative autoradiographic studies of brain edema and a comparison of multi-isotope autoradiographic techniques. Adv Neurol (1980) 1.03

Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis. Anticancer Res (1984) 1.03

Regional measurements of blood flow in experimental RG-2 rat gliomas. Cancer Res (1983) 1.01

Transport of material between brain extracellular fluid, brain cells and blood. Fed Proc (1974) 1.00

Methods for Quantifying the transport of drugs across brain barrier systems. Pharmacol Ther (1981) 0.99

Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas. Cancer Res (1983) 0.97

Selection of experimental conditions for the accurate determination of blood--brain transfer constants from single-time experiments: a theoretical analysis. J Cereb Blood Flow Metab (1983) 0.97

Increased blood-brain transfer in a rabbit model of acute liver failure. Gastroenterology (1983) 0.95

Regional blood flow in RT-9 brain tumors. J Neurosurg (1983) 0.94

Dexamethasone effects on [125I]albumin distribution in experimental RG-2 gliomas and adjacent brain. J Cereb Blood Flow Metab (1987) 0.93

Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging. AJNR Am J Neuroradiol (2010) 0.93

Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration. J Neurosurg (1991) 0.91

Drug streaming during intra-arterial chemotherapy. J Neurosurg (1986) 0.91

Peritoneal absorption of macromolecules studied by quantitative autoradiography. Am J Physiol (1985) 0.90

Demyelinating radiculopathy in the Kearns-Sayre syndrome: a clinicopathological study. Ann Neurol (1980) 0.89

Local blood-to-tissue transport in Walker 256 metastatic brain tumors. J Neurooncol (1984) 0.89

A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis. J Cereb Blood Flow Metab (1985) 0.88

Experimental gliomas: an autoradiographic study of the endothelial component. Neurology (1980) 0.88

Local distribution and concentration of intravenously injected 131I-9.2.27 monoclonal antibody in human malignant melanoma. Cancer Res (1989) 0.87

Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat Rep (1981) 0.87

Intravascular streaming and variable delivery to brain following carotid artery infusions in the Sprague-Dawley rat. J Cereb Blood Flow Metab (1988) 0.87

A distributed model of peritoneal-plasma transport: tissue concentration gradients. Am J Physiol (1985) 0.86

Dexamethasone effects on vascular volume and tissue hematocrit in experimental RG-2 gliomas and adjacent brain. J Neurooncol (1988) 0.86

Cerebrovascular transport of [125I]quinuclidinyl benzilate, [3H]cyclofoxy, and [14C]iodoantipyrine. Am J Physiol (1990) 0.86

Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas. Cancer Res (1990) 0.85

A model for human medulloblastoma. Growth, morphology, and chromosomal analysis in vitro and in athymic mice. J Neuropathol Exp Neurol (1983) 0.84

Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas. J Nucl Med (1998) 0.84

Regional blood flow in ethylnitrosourea-induced brain tumors. Ann Neurol (1983) 0.83

The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neuro Oncol (1999) 0.83

Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy. Cancer Res (1987) 0.83

Absence of host-site influence on angiogenesis, blood flow, and permeability in transplanted RG-2 gliomas. Drug Metab Dispos (1999) 0.83

Carotid artery mixing with diastole-phased pulsed drug infusion. J Neurosurg (1987) 0.82

Regional blood-to-tissue transport in RT-9 brain tumors. J Neurosurg (1983) 0.82

Role of radionuclide imaging in trials of antiangiogenic therapy. Acad Radiol (2000) 0.82

Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer Treat Rep (1977) 0.82

Regional blood-to-tissue transport in ethylnitrosourea-induced brain tumors. Ann Neurol (1983) 0.82

Dominantly inherited pseudohypertrophic muscular dystrophy with internalized capillaries. Arch Neurol (1980) 0.82

Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects. J Neuropsychiatry Clin Neurosci (1998) 0.81

Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats. J Natl Cancer Inst (1987) 0.81

Focal cerebral vasculitis associated with circulating immune complexes and brain irradiation. Ann Neurol (1986) 0.81

Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research. J Neurooncol (1991) 0.80

Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82. J Neurosurg (1996) 0.80

Autoregulation of cerebral blood flow in the newborn beagle puppy. Biol Neonate (1985) 0.80

Kinetic analysis of cerebrovascular transport based on indicator diffusion technique. Am J Physiol (1989) 0.79

Changes in blood-brain transfer parameters induced by hyperosmolar intracarotid infusion and by metastatic tumor growth. Adv Exp Med Biol (1980) 0.79

Regional blood flow and blood-to-tissue transport in five brain tumor models. Implications for chemotherapy. Prog Exp Tumor Res (1984) 0.79

Regional brain measurement of Bmax and KD with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat. J Cereb Blood Flow Metab (1991) 0.79

Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange. Cancer Res (1987) 0.79

The microcirculation of rat circumventricular organs and pituitary gland. Brain Res Bull (1987) 0.79

Comparison of iron-59, indium-111, and gallium-69 transferrin as a macromolecular tracer of vascular permeability and the transferrin receptor. J Nucl Med (1989) 0.79

Regional blood flow, capillary permeability, and glucose utilization in two brain tumor models: preliminary observations and pharmacokinetic implications. Cancer Treat Rep (1981) 0.79

Gallium-transferrin as a macromolecular tracer of vascular permeability. Int J Rad Appl Instrum B (1988) 0.78

Technetium-99m-d,l-HM-PAO, the development of a new class of 99mTc-labeled tracers: an overview. J Cereb Blood Flow Metab (1988) 0.78

Noninvasive measurement of arterial blood plasma concentration of iodinated contrast agents from CT scans of human brain. J Comput Assist Tomogr (1994) 0.78

Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI. J Neurooncol (2000) 0.77

The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas. Ann Neurol (1987) 0.77

The effects of dexamethasone on experimental brain tumors: I. Transcapillary transport and blood flow in RG-2 rat gliomas. J Neurooncol (1995) 0.77

Regional blood flow in avian sarcoma virus (ASV)-induced brain tumors. Neurology (1983) 0.77

Local blood flow in Walker 256 metastatic brain tumors. J Neurooncol (1984) 0.77

Regional blood-to-tissue transport in avian sarcoma virus (ASV)-induced brain tumors. Neurology (1983) 0.77

Pharmacodynamics and the blood-brain barrier. Natl Cancer Inst Monogr (1977) 0.77

Blood-tumor barrier disruption controversies. J Cereb Blood Flow Metab (1991) 0.77

Simultaneous measurements of blood flow and blood-to-tissue transport in xenotransplanted medulloblastomas. Cancer Res (1987) 0.76

Regional cerebral blood flow in the beagle puppy model of neonatal intraventricular hemorrhage: studies during systemic hypertension. Neurology (1983) 0.76

Apparent glucose utilization in Walker 256 metastatic brain tumors. J Neurooncol (1986) 0.76

Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion. Cancer Treat Rep (1977) 0.76

The effects of dexamethasone on transcapillary transport in experimental brain tumors: II. Canine brain tumors. J Neurooncol (1995) 0.76

Regional cerebral blood flow in the newborn beagle pup: the germinal matrix is a "low-flow" structure. Pediatr Res (1982) 0.76

The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas. Neurology (1984) 0.76